Anterix Inc.
ATEX· Nasdaq
Filed Jun 26, 2024 · 10-K · 87 days after period end · 0001304492-24-000077
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021 |
|---|---|---|---|---|
| Revenue | $1.26M | $608.00K | $335.00K | $181.00K |
| Net Income | -$9.41M | $15.54M | -$11.02M | -$10.94M |
| EPS Diluted | — | — |
Anterix Inc. · CIK 1304492 · Engraved from SEC EDGAR
| — |
| -$0.62 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Mar 31, 2024 · filed Jun 26, 2024 · 87 d after period end